Point-of-care testing is increasingly pivoting to non-COVID applications, such as respiratory panels, STIs, and antimicrobial resistance surveillance. Investment, M&A, and R&D activity remain robust ...

NEW YORK – Visby Medical announced Tuesday that it has raised about $55 million in a recent financing round with the total potentially reaching $65 million.

The European direct-to-consumer genetic testing market is expected to reach USD 3.78 billion by 2035, growing from an ...

What if people could detect cancer and other diseases with the same speed and ease as a pregnancy test or blood glucose meter ...